In an urgent bid to safeguard patient well-being and stamp out hazardous hospital malpractices, the Directorate General of Health Services (DGHS) has issued a nationwide advisory calling for an immediate clampdown on the re-sterilisation and reuse of single-use medical devices (SUDs). The health directorate instructed state authorities and Union Territories to enforce stringent oversight across both private and public medical institutions to eliminate risks of contamination and life-threatening infections.
Key Highlights & Background
- Nationwide Directive: The DGHS directed State Health Secretaries, Drug Controllers, and the DCGI to crack down on healthcare facilities reprocessing disposable surgical tools.
- Critical Departments Implicated: Unauthorised reuse has been identified in high-stakes fields such as cardiology, neurosurgery, nephrology, oncology, and cardiothoracic surgery.
- Unethical Billing: Evidence surfaced showing facilities billing patients and government reimbursement schemes the full original price for already used, recycled devices.
- Regulatory Infractions: The practice directly flouts the Drugs and Cosmetics Act of 1940, the Medical Devices Rules of 2017, and the Clinical Establishments Act of 2010.
In-Depth Details
The intervention by the central health authority follows growing alarm over cost-cutting methods employed by several corporate and private healthcare facilities. By cleaning, resterilising, and reusing single-use catheters, balloons, guides, and specialized surgical equipment, institutions compromise product integrity. Many disposable devices feature sensitive micro-mechanisms or microscopic lumens that cannot be safely purged of biological material, creating acute vectors for bloodstream infections, tissue inflammation, and unexpected mechanical failure during procedures.
Beyond immediate clinical hazards, the DGHS highlighted an egregious financial malpractice: hospitals often charge patients the full retail fee of a brand-new instrument despite administering a recycled product. In multiple documented instances, healthcare operators even submitted fraudulent insurance reimbursement claims to public health coverage schemes for these single-use items, translating patient safety shortcuts into illicit financial gains.
To stop this practice, the DGHS mandated that all healthcare providers comply strictly with Original Equipment Manufacturer (OEM) guidelines. Regulators pointed out that medical devices are specifically tested and certified for single clinical interventions, meaning unauthorized reprocessing invalidates quality assurances and constitutes an actionable offense under Indian law.
Public Reaction & What Happens Next
The directive was welcomed by patient advocacy groups and the domestic manufacturing sector. The Association of Indian Medical Device Industry (AiMeD) endorsed the Centre's decisive stance. AiMeD Forum Coordinator Rajiv Nath affirmed that consumer safety must override commercial convenience, noting that legal accountability for adverse events or equipment malfunctions caused by unauthorized reuse must be placed squarely on the offending hospital and medical personnel rather than the original manufacturer.
State drug control administrations have been asked to initiate surprise site inspections, review inventory and sterilization logs, and institute strict regulatory proceedings—including license revocation and penal prosecution—against facilities defying the directive.
Frequently Asked Questions (FAQ)
Q: Why is reusing single-use medical devices hazardous?A: Single-use devices are constructed from materials not designed to endure thermal or chemical re-sterilisation. Reusing them can cause material degradation, mechanical breakdown inside the body, and cross-contamination from residual pathogens, potentially leading to severe secondary infections.
Q: What legal consequences do hospitals face for reusing disposable equipment?A: Establishments violating these directives risk regulatory penalties, cancellation of their operating licenses, and prosecution under the Clinical Establishments Act, Drugs and Cosmetics Act, and relevant consumer protection statutes.
Reporting reference: Information analyzed from public news wires and Tishha News.
Tags: Healthcare, DGHS, Medical Devices, Public Health, India News
